Revance Therapeutics, Inc.
Nashville, TN
- UEI
- HY78DQBTLLG3
- CAGE
- 9QP59
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1222 Demonbreun St Suite 2000, Nashville, TN 37203, USA
- Website
- revance.com
- Founded
- 1999
- Employees
- 251-1K
- Estimated annual revenue
- $100M-$250M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Quick answers
Is Revance Therapeutics, Inc. registered in SAM.gov?
Yes. Revance Therapeutics, Inc.'s SAM.gov registration is active through April 29, 2027.
What is Revance Therapeutics, Inc.'s CAGE code?
Revance Therapeutics, Inc.'s CAGE code is 9QP59, and its Unique Entity ID (UEI) is HY78DQBTLLG3.
Which contract vehicles does Revance Therapeutics, Inc. hold?
Revance Therapeutics, Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
On GovTribe
See Revance Therapeutics, Inc.'s full federal record
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors